S&P 500
$5,787.84
-0.9%
-$54.17
DJI
$41,496.98
-0.9%
-$362.11
NASDAQ
$18,698.23
-1.2%
-$227.51
Bitcoin
108,603.00
-2.4%
-2,723.58
AAPL
$196.84
-2.2%
-$4.52
AMZN
$200.15
-1.5%
-$2.95
GOOG
$170.36
-0.9%
-$1.62
META
$628.07
-1.3%
-$8.50
MSFT
$451.62
-0.7%
-$3.24
NVDA
$130.40
-1.8%
-$2.43
TSLA
$337.49
-1.0%
-$3.55
Free Analysis
Join Over Half a Million Premium Members And Get More In-Depth Stock Guidance and Research
Century Therapeutics (NASDAQ: IPSC)
$0.56
(-2.4%)
-$0.01
Price as of May 23, 2025, 9:41 a.m. ET
Century Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Century Therapeutics Company Info
Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.